• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Preventing Clinical Inertia in Early Treatment Management of Type 2 Diabetes

home / stakeholder-summit / preventing-clinical-inertia-in-early-treatment-management-of-type-2-diabetes

The information discussed in this series is a consensus from the Diabetes Cardiorenal & Metabolism Institute (DCMi) think Tank, a workshop consisting of 17 medical experts to create treatment consensuses based on data and expert opinion, for patients with complex multimorbid diseases plateauing or worsening in outcomes despite the emergence of numerous therapeutic options available. The DCMi will soon have a published consensus paper on early intervention and intensive management of the patient with diabetes and cardio-renal-metabolic diseases which compliments the DCRM multi-specialty practice accommodations.

© 2024 MJH Life Sciences
All rights reserved.